Molecular and biochemical characterisation of a novel mutation in POLG associated with Alpers syndrome
2011

Study of a New POLG Mutation Linked to Alpers Syndrome

Sample size: 1 publication Evidence: moderate

Author Information

Author(s): André Schaller, Dagmar Hahn, Christopher B. Jackson, Ilse Kern, Christophe Chardot, Dominique C. Belli, Sabina Gallati, Jean-Marc Nuoffer

Primary Institution: University Hospital Bern

Hypothesis

The study investigates the effects of a novel POLG mutation in a child with Alpers syndrome and valproic acid-induced liver failure.

Conclusion

The study confirms that mtDNA depletion can be tissue-specific and emphasizes the importance of POLG analysis for clinical management.

Supporting Evidence

  • The boy had a novel splice site mutation in POLG that led to mtDNA depletion.
  • The mutations resulted in a significant reduction of mtDNA in the liver, correlating with decreased oxidative phosphorylation activities.
  • The study highlights the need for POLG analysis before starting valproic acid treatment.

Takeaway

A little boy had a serious health problem because of a new mutation in his DNA that affected his energy production, and doctors learned that checking this DNA can help treat similar cases better.

Methodology

The study used quantitative PCR to measure mtDNA content and assessed oxidative phosphorylation activities in various tissues.

Limitations

The study is based on a single case, which may limit the generalizability of the findings.

Participant Demographics

A 3.5-year-old boy from non-consanguineous parents.

Digital Object Identifier (DOI)

10.1186/1471-2377-11-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication